From the Sector

Reset
148 results
FET: New Senior Materials and Process Scientist (c) FET
R&D Manager Dr Jonny Hunter (left) welcomes Dr Kristoffer Kortsen, Senior Materials and Process Scientist
28.02.2024

FET: New Senior Materials and Process Scientist

Fibre Extrusion Technology Ltd (FET) of Leeds, UK has appointed Dr Kristoffer Kortsen as Senior Materials and Process Scientist. He will report directly to R&D Manager, Dr Jonny Hunter, who joined FET in early 2023 in a growing Research and Development team.

Kortsen’s main area of work is in Gel Spinning of UHMWPE (Ultra-High Molecular Weight Polyethylene). His contribution will help provide gel spinning expertise and equipment in the near future to a range of industries including medical, aerospace, defence aerospace and marine.

Fibre Extrusion Technology Ltd (FET) of Leeds, UK has appointed Dr Kristoffer Kortsen as Senior Materials and Process Scientist. He will report directly to R&D Manager, Dr Jonny Hunter, who joined FET in early 2023 in a growing Research and Development team.

Kortsen’s main area of work is in Gel Spinning of UHMWPE (Ultra-High Molecular Weight Polyethylene). His contribution will help provide gel spinning expertise and equipment in the near future to a range of industries including medical, aerospace, defence aerospace and marine.

He completed a Master’s in chemistry at KU Leuven, graduating magna cum laude in 2018. For his Master’s placement, he worked on the production of impact modifier additives for PVC at Kaneka Belgium. Continuing a partnership with this international chemical manufacturing company, he joined the Howdle group at the University of Nottingham for a PhD project looking into the industrial potential of scCO2 dispersion polymerisations for additive production. After graduating, he worked in the Shaver group at the University of Manchester, developing a holistic approach to plastics recycling and sustainability across the many stakeholders in the field.

Source:

Fibre Extrusion Technology Ltd (FET)

AkzoNobel participates in research program with SusInkCoat project (c) The Dutch Research Council (NWO)
05.02.2024

AkzoNobel participates in research program with SusInkCoat project

More than 82 companies, businesses and social organizations – including AkzoNobel – are involved in a major Dutch research program focused on developing new technologies that will help solve some of today’s societal challenges.
 
Seven broad consortia have been established as part of the government-funded “Perspectief” program, with AkzoNobel set to play a leading role in the SusInkCoat project, which will explore how to make inks and coatings more sustainable.

The company will work together with private partners and other societal stakeholders to develop new materials, processes and applications to improve the durability, functionality and recyclability of coatings, thin films and inks. The program, which will run for the next five years, is backed by the Ministry of Economic Affairs and Climate Policy and the Dutch Research Council (NWO).

More than 82 companies, businesses and social organizations – including AkzoNobel – are involved in a major Dutch research program focused on developing new technologies that will help solve some of today’s societal challenges.
 
Seven broad consortia have been established as part of the government-funded “Perspectief” program, with AkzoNobel set to play a leading role in the SusInkCoat project, which will explore how to make inks and coatings more sustainable.

The company will work together with private partners and other societal stakeholders to develop new materials, processes and applications to improve the durability, functionality and recyclability of coatings, thin films and inks. The program, which will run for the next five years, is backed by the Ministry of Economic Affairs and Climate Policy and the Dutch Research Council (NWO).

“Our discussions about collaborating with our SusInkCoat partners have been very positive,” says AkzoNobel’s R&D Director of Scientific Academic Programs, André van Linden, who is also the co-lead of SusInkCoat. “We’re all facing the same societal challenges – how to become more circular – and we’re looking for the same solutions in different application areas. But we’ve never done that together for this specific research topic, so we need an ecosystem to help us solve these challenges.
 
Van Linden adds that the program – one of many R&D projects the company is involved with – will also support AkzoNobel’s ambition to achieve 50% less carbon emissions in its own operations – and across the value chain – by 2030.
 
 “We want to make the recyclability of materials - such as furniture, building materials and steel constructions - easier by introducing functionalities like self-healing, higher durability and triggered release,” he continues. “The more you can leave the materials in their original state, the more sustainably you can operate.”

AkzoNobel will be collaborating with Canon, Evonik, GFB, PTG and RUG Ventures, who together possess extensive knowledge of market demands, supply chains and production processes. All the SusInkCoat partners will also work with academic researchers at several Dutch universities in an effort to identify promising developments that can be commercialized, used for education purposes or for outreach to the public.

Research being conducted by the other six consortia includes investigating methods to make tastier plant-based food; flat optics for more sustainable hi-tech equipment; and cheaper and more accessible medical imaging technology.

More information:
AkzoNobel Coatings Sustainability
Source:

AkzoNobel

KARL MAYER TURKEY appoints General Manager (c) KARL MAYER GROUP
Toros Greenhalgh, General Manager of KARL MAYER TURKEY
02.02.2024

KARL MAYER TURKEY appoints General Manager

Toros Greenhalgh becomes General Manager of the new KARL MAYER subsidiary in Türkiye

In October 2023, the KARL MAYER GROUP established its own site in Bursa, Türkiye, thus increasing its presence in one of its most important markets. KARL MAYER TURKEY will meet increasing customer demands for after-sales service, spare parts (Care Solutions), and academy, in the sectors of warp knitting and warp preparation, while KARL MAYER’s long-standing regional representative ERKO focuses on machine sales.

Toros Greenhalgh was appointed General Manager of KARL MAYER TURKEY on February 1st of this year. Holding a degree in mechanical engineering and materials science from the University of Birmingham, he comes with experience in the fields of industrial plant construction management, renewable energy technologies, and the distribution of medical devices. For the past seven years he has been active in the sector of textile machinery through ERKO with particular focus on KARL MAYER machine sales, service, and spare parts.

Toros Greenhalgh becomes General Manager of the new KARL MAYER subsidiary in Türkiye

In October 2023, the KARL MAYER GROUP established its own site in Bursa, Türkiye, thus increasing its presence in one of its most important markets. KARL MAYER TURKEY will meet increasing customer demands for after-sales service, spare parts (Care Solutions), and academy, in the sectors of warp knitting and warp preparation, while KARL MAYER’s long-standing regional representative ERKO focuses on machine sales.

Toros Greenhalgh was appointed General Manager of KARL MAYER TURKEY on February 1st of this year. Holding a degree in mechanical engineering and materials science from the University of Birmingham, he comes with experience in the fields of industrial plant construction management, renewable energy technologies, and the distribution of medical devices. For the past seven years he has been active in the sector of textile machinery through ERKO with particular focus on KARL MAYER machine sales, service, and spare parts.

More information:
Karl Mayer Manager Turkey
Source:

KARL MAYER GROUP

flat knitting machine © Knitwear Lab
09.01.2024

Knitwear Lab relies on CREATE PLUS patterning software by STOLL

The Dutch company Knitwear Lab helps visions become reality. The creative think tank offers capacities in the areas of R&D, design, knitwear development and production of prototypes and small quantities and has thus implemented a wide range of projects in recent years. The objects range from medical products and high-tech sportswear to smart textiles with integrated sensors. Sustainability activities are also part of the repertoire, such as the production of yarns from recycled waste.

The Dutch company Knitwear Lab helps visions become reality. The creative think tank offers capacities in the areas of R&D, design, knitwear development and production of prototypes and small quantities and has thus implemented a wide range of projects in recent years. The objects range from medical products and high-tech sportswear to smart textiles with integrated sensors. Sustainability activities are also part of the repertoire, such as the production of yarns from recycled waste.

Knitwear Lab operates at two locations for its diverse tasks: Almere in the Netherlandsis available for development work. In Istanbul, there is a branch for production. Both Knitwear Lab sites each have five STOLL flat knitting machines, including models from the modern ADF range. Prototypes are produced in Almere and there is small-scale production. The production plant in Istanbul specializes in the manufacture of high-quality knitwear in small quantities. STOLL is also involved in the creative processes. For the industrial development of knitwear, Knitwear Lab offers Virtual Knitting, a revolutionary method that combines virtual and physical elements of pattern development and knitwear production to reduce waste and pre-production steps. Customers can use Virtual Knitting to create realistic, producible collections, simplify their design iteration processes and take advantage of the wide range of real-life colorways. The basis for this is comprehensive knitwear expertise, the latest 3D software and the CREATE PLUS patterning software, which was developed by STOLL together with KM.ON.

"The 3D visualization of CREATE simplifies communication with the customer considerably. We use this function every day," says Annika Klaas, Senior Knitwear Programmer. She personally appreciates the uncomplicated grading and exchange of stitch dimensions and the much faster and more efficient work with Dimensioned Shapes that this makes possible. This helps her in her day-to-day work. "We often have requests to realize the same product in different yarns, which now works much faster," says the programmer. Further simplifications would include minor optimizations in terms of the efficiency and user-friendliness of programming and additional import and export options for shapes. Discussions on implementation are already underway.

Source:

KARL MAYER GROUP

03.11.2023

Hologenix named 2023 Inc. Power Partner

Hologenix® is an honoree on the second annual Power Partner Awards list by Inc. Business Media. Inc.’s 2023 Power Partner Awards feature B2B organizations across the globe that have proven track records supporting entrepreneurs and helping startups grow. There were 389 companies in all who achieved top marks from clients for being instrumental in their success and made the final list. Hologenix was recognized in the Health & Wellness category, which focuses on companies that provide health and wellness products or services. In order to achieve this status, customers provided written testimonials detailing their experience in working with Hologenix as a partner.

Hologenix® is an honoree on the second annual Power Partner Awards list by Inc. Business Media. Inc.’s 2023 Power Partner Awards feature B2B organizations across the globe that have proven track records supporting entrepreneurs and helping startups grow. There were 389 companies in all who achieved top marks from clients for being instrumental in their success and made the final list. Hologenix was recognized in the Health & Wellness category, which focuses on companies that provide health and wellness products or services. In order to achieve this status, customers provided written testimonials detailing their experience in working with Hologenix as a partner.

“Our business is set up to succeed when our partners succeed, so we are grateful that our partners have affirmed the superior level of support we aim to provide,” said Seth Casden, Hologenix CEO and Co-Founder. “CELLIANT offers something unique to world-class brands looking to deliver health and wellness benefits. Our proprietary technology offers a key textile differentiator for their products, from apparel, bedding and furnishings to medical-use fabrics, bandages and wraps, transportation seating and even saunas.”

More information:
Hologenix Celliant Bedding apparel
Source:

Hologenix, LLC

03.11.2023

Lenzing implements performance program in response to lack of market recovery

  • Revenue of EUR 1.87 bn and EBITDA of EUR 219.1 mn in the first three quarters of 2023
  • Positive free cash flow of EUR 27.3 mn in the third quarter
  • Implementation of performance program focusing on positive free cash flow, strengthened sales and margin growth and sustainable cost excellence
  • Modernization and conversion of Indonesian site successfully completed – EU Ecolabel received

The anticipated recovery in markets relevant for the Lenzing Group has to date failed to materialize. The continued sharp increase in raw material and energy costs on the one hand and very subdued demand on the other had a negative impact on Lenzing’s business trends as well as on industry as a whole during the reporting period.

  • Revenue of EUR 1.87 bn and EBITDA of EUR 219.1 mn in the first three quarters of 2023
  • Positive free cash flow of EUR 27.3 mn in the third quarter
  • Implementation of performance program focusing on positive free cash flow, strengthened sales and margin growth and sustainable cost excellence
  • Modernization and conversion of Indonesian site successfully completed – EU Ecolabel received

The anticipated recovery in markets relevant for the Lenzing Group has to date failed to materialize. The continued sharp increase in raw material and energy costs on the one hand and very subdued demand on the other had a negative impact on Lenzing’s business trends as well as on industry as a whole during the reporting period.

Revenue in the first three quarters of 2023 decreased by 5.3 percent year-on-year to EUR 1.87 bn. This reduction was primarily due to lower fiber revenues, while pulp revenues were up. The earnings trend was mainly influenced by the market environment. As a consequence, earnings before interest, tax, depreciation and amortization (EBITDA) in the reporting period decreased by 16.7 percent year-on-year to EUR 219.1 mn. The net result after tax amounted to minus EUR 96.7 mn (compared with EUR 74.9 mn in the first three quarters of 2022), while earnings per share amounted to minus EUR 4.90 (compared with EUR 2.16 in the first three quarters of 2022).

Outlook
According to the IMF, a full return of the global economy to pre-pandemic growth rates appears increasingly out of reach in the coming quarters. In addition to the consequences of the pandemic and the ongoing war in Ukraine, growth is also being influenced by restrictive monetary policy and extreme weather events. The consequences of the renewed military confrontation in the Middle East are not yet foreseeable. Overall, the IMF warns of greater risks to global financial stability, and expects the growth rate to decrease to 3 percent this year and to 2.9 percent next year.

The currency environment is expected to remain volatile in the regions of relevance to Lenzing.

The general market environment is continuing to weigh on the consumer climate and on sentiment in the industries relevant to Lenzing.

In the trend-setting market for cotton, the current 2023/24 crop season is emerging as a further 1.7 mn tonnes of inventory build-up, following 1.8 mn tonnes of inventory build-up in the previous season.

Earnings visibility remains severely limited overall.

Lenzing is fully on track with the implementation of the reorganization and cost reduction program and on this basis is implementing a comprehensive performance program focused on positive free cash flow, strengthened sales and margin growth as well as sustainable cost excellence. The overarching goal is to position Lenzing even more strongly and to further increase its crisis resilience.

In structural terms, Lenzing continues to anticipate growth in demand for environmentally responsible fibers for the textile and clothing industry as well as the hygiene and medical sectors. As a consequence, Lenzing is very well positioned with its “Better Growth” strategy and plans to continue driving growth with specialty fibers as well as its sustainability goals, including the trans-formation from a linear to a circular economy model.

The successful implementation of the key projects in Thailand and Brazil as well as the investment projects in China and Indonesia will further strengthen Lenzing’s positioning in this respect.

Taking the aforementioned factors into consideration, the Lenzing Group continues to expect that EBITDA for the 2023 financial year will lie in a range between EUR 270 mn and EUR 330 mn.

Source:

Lenzing AG

Manjushree Group enters Indian nonwovens market with Reifenhäuser Reicofil line (c) Reifenhäuser GmbH & Co. KG Maschinenfabrik
06.10.2023

Manjushree Group enters Indian nonwovens market with Reifenhäuser Reicofil line

After four decades in the packaging industry, the Manjushree Group is entering the Indian nonwovens market. The entrepreneurs rely on a flexible RF Smart Composite line from Reifenhäuser Reicofil to meet very different customer requirements.

The Manjushree Group operated a blown film line for packaging materials for the tea industry in the eastern part of India as early as 1983. In the years that followed, Manjushree Technopack Ltd. developed into one of the largest suppliers of solutions for rigid plastic products in South Asia - and the family business grew into a group with several business segments. In 2018, the entrepreneurial family repositioned itself: it sold its previous core business to a financial investor and established Manjushree Ventures with footholds in start-up financing, real estate business, and manufacturing - the largest of which is Manjushree Spntek as a producer of high-quality spunmelted fabrics.

After four decades in the packaging industry, the Manjushree Group is entering the Indian nonwovens market. The entrepreneurs rely on a flexible RF Smart Composite line from Reifenhäuser Reicofil to meet very different customer requirements.

The Manjushree Group operated a blown film line for packaging materials for the tea industry in the eastern part of India as early as 1983. In the years that followed, Manjushree Technopack Ltd. developed into one of the largest suppliers of solutions for rigid plastic products in South Asia - and the family business grew into a group with several business segments. In 2018, the entrepreneurial family repositioned itself: it sold its previous core business to a financial investor and established Manjushree Ventures with footholds in start-up financing, real estate business, and manufacturing - the largest of which is Manjushree Spntek as a producer of high-quality spunmelted fabrics.

Since February 2023, Manjushree Spntek has been producing high-performance spunmelts on an RF Smart Composite line from Reifenhäuser Reicofil - benefiting both from many years of experience in the packaging industry and from experience with Reifenhäuser's blown film lines. "We know a lot about plastic extrusion, for example when it comes to line operating parameters such as temperature and pressure. Processing is similar in both industries," explains Rajat Kedia. "The main difference is the distribution of the products: In plastic packaging, we had an established customer base and sold a lot of material to the big consumer goods manufacturers. The nonwovens market in India, on the other hand, is still forming, with thousands of small companies currently getting involved." These serve customers in their regions, such as hospitals.

The RF Smart Composite line is a standardized spunmelt line for smaller and emerging markets. The line produces nonwovens of the highest Reicofil quality with appropriately adapted throughput. This makes it ideally suited for applications in hygiene and medical technology and, with typically 8,200 annual production hours, it is extremely reliable. In addition, operators can start production quickly because in many cases the line can be integrated into existing buildings.

Before production could start, Manjushree built a new production building in Bidadi, a town an hour's drive from Bangalore International Airport. The building is designed to be sustainable: It uses natural light and fresh air, has comprehensive contamination control, and obtains almost all of its energy from renewable sources. Reifenhäuser Reicofil then installed, commissioned and tested the RF Smart Composite line.

Since February 2023, Manjushree Spntek has been producing high-quality spunmelted nonwovens, including ultra-soft fabrics and fabrics with special coatings for customers in the hygiene and medical industries. The material can be used, for example, for baby diapers and feminine hygiene products, but also for medical articles ranging from surgical gowns to surgical drapes.

Source:

Reifenhäuser GmbH & Co. KG Maschinenfabrik

ANDRITZ: Extra-wide carding machine for Italian nonwovens producer (c) ANDRITZ
From left to right: Mr. Gianni Boscolo, CEO of Albis, and Mr. Fabien Ravier, Managing Director of ANDRITZ Asselin-Thibeau
27.09.2023

ANDRITZ: Extra-wide carding machine for Italian nonwovens producer

International technology group ANDRITZ has successfully started up the new carding machine and opening/blending line it delivered to Albis in Roasio, Vercelli, Italy.

With its large working width of 5.10 meters, the machine allows for the production of nonwoven fabrics tailored to specific customer requirements while maintaining excellent properties and consistent quality. One example is Albis Curacell ®, a multilayer composite nonwoven fabric in a weight range between 35 and 70 gsm that is produced with a fully water-free patented process and is able to absorb liquid flows of over seven times its own weight. The production line also includes an advanced upstream opening and blending system from ANDRITZ.

Albis, a privately owned group founded in Italy in 1995 by Gianni Boscolo, has been a major player in the nonwoven market for over three decades. Through continuous research and development, the company offers innovative, high-quality nonwoven solutions across various sectors, including hygiene, medical, personal care, textiles, filtration, and agriculture.

International technology group ANDRITZ has successfully started up the new carding machine and opening/blending line it delivered to Albis in Roasio, Vercelli, Italy.

With its large working width of 5.10 meters, the machine allows for the production of nonwoven fabrics tailored to specific customer requirements while maintaining excellent properties and consistent quality. One example is Albis Curacell ®, a multilayer composite nonwoven fabric in a weight range between 35 and 70 gsm that is produced with a fully water-free patented process and is able to absorb liquid flows of over seven times its own weight. The production line also includes an advanced upstream opening and blending system from ANDRITZ.

Albis, a privately owned group founded in Italy in 1995 by Gianni Boscolo, has been a major player in the nonwoven market for over three decades. Through continuous research and development, the company offers innovative, high-quality nonwoven solutions across various sectors, including hygiene, medical, personal care, textiles, filtration, and agriculture.

Source:

ANDRITZ AG

27.09.2023

CELLIANT meets updated requirements for Class 1 Medical Devices

The European Union (EU) has upgraded the requirements for the Class 1 Medical Device designation and Hologenix®, creators of CELLIANT®, has met the stricter requirements for this important market. This means that compliant manufacturers can continue to use the CE mark on their EU products containing CELLIANT.

Brand partners simply need to comply with the requirements that Hologenix provides, and do not have to pursue regulations on their own. Regulatory status validates the science and technology behind CELLIANT, a natural blend of bioceramic minerals that absorb body heat and reflect it back as therapeutic infrared energy.

The list of products that are now registered in the EU as Class 1 Medical Devices has grown considerably since 2014 when Hologenix first sought registration and now includes bed blankets, bed sheets, duvets, duvet covers, mattresses, mattress covers, pillows, heat-reflective upper and lower torso garments, therapeutic diabetic socks, compression socks/stockings, support bandages, wraps and limb mobilization/support skin adhesive tape.  

The European Union (EU) has upgraded the requirements for the Class 1 Medical Device designation and Hologenix®, creators of CELLIANT®, has met the stricter requirements for this important market. This means that compliant manufacturers can continue to use the CE mark on their EU products containing CELLIANT.

Brand partners simply need to comply with the requirements that Hologenix provides, and do not have to pursue regulations on their own. Regulatory status validates the science and technology behind CELLIANT, a natural blend of bioceramic minerals that absorb body heat and reflect it back as therapeutic infrared energy.

The list of products that are now registered in the EU as Class 1 Medical Devices has grown considerably since 2014 when Hologenix first sought registration and now includes bed blankets, bed sheets, duvets, duvet covers, mattresses, mattress covers, pillows, heat-reflective upper and lower torso garments, therapeutic diabetic socks, compression socks/stockings, support bandages, wraps and limb mobilization/support skin adhesive tape.  

The transition to the Medical Device Regulations in the EU for CELLIANT Class 1 medical devices includes more stringent requirements to demonstrate medical device safety for users, a refined quality management system and detailed technical documents.

More information:
Hologenix Celliant medical textiles
Source:

Hologenix, LLC

02.08.2023

Lenzing: Business Performance in the first half of 2023

  • Revenue of EUR 1.25 bn and EBITDA of EUR 136.5 mn in the first half of 2023
  • EBITDA and net result for the period significantly improved compared with the first quarter of 2023
  • Cost-cutting program and measures to strengthen sales activities being implemented as planned
  • Liquidity position strengthened by successful capital increase and extension of credit terms
  • Production of TENCEL™ brand modal fibers successfully launched in China

The business performance of the Lenzing Group, a leading global supplier of specialty fibers for the textile and nonwoven industries, largely reflected the subdued market trends in the first half of 2023. After the market environment deteriorated significantly in the second half of 2022, signs of recovery were evident during the first and second quarters of 2023 in terms of both raw material and energy costs as well as demand. Textile fibers recorded improving demand, and business with nonwoven fibers and with dissolving wood pulp proved to be very stable.

  • Revenue of EUR 1.25 bn and EBITDA of EUR 136.5 mn in the first half of 2023
  • EBITDA and net result for the period significantly improved compared with the first quarter of 2023
  • Cost-cutting program and measures to strengthen sales activities being implemented as planned
  • Liquidity position strengthened by successful capital increase and extension of credit terms
  • Production of TENCEL™ brand modal fibers successfully launched in China

The business performance of the Lenzing Group, a leading global supplier of specialty fibers for the textile and nonwoven industries, largely reflected the subdued market trends in the first half of 2023. After the market environment deteriorated significantly in the second half of 2022, signs of recovery were evident during the first and second quarters of 2023 in terms of both raw material and energy costs as well as demand. Textile fibers recorded improving demand, and business with nonwoven fibers and with dissolving wood pulp proved to be very stable.

Outlook
The war in Ukraine and the more restrictive monetary policy pursued by many central banks in order to combat inflation are expected to continue to influence global economic activity. The IMF warns that risks remain elevated overall and forecasts growth of 3 percent for both 2023 and 2024. The currency environment is expected to remain volatile in the regions of relevance to Lenzing.

This market environment continues to weigh on the consumer climate and on sentiment in the industries relevant to Lenzing. Recently, however, the outlook brightened somewhat according to a global survey by the ITMF.*

In the trend-setting market for cotton, signs are emerging of a further buildup of stocks in the current 2022/23 crop season. Initial forecasts also see a further buildup of stocks in 2023/24, albeit to a lesser extent.

However, despite signs of recovery in both demand and raw material and energy costs, earnings visibility remains limited overall.

Lenzing is fully on track with the implementation of its reorganization and cost-cutting program. These and further measures are aimed at positioning Lenzing in the best possible way for the expected market recovery.

In structural terms, Lenzing continues to anticipate growth in demand for environmentally responsible fibers for the textile and clothing industry as well as the hygiene and medical sectors. As a consequence, Lenzing is very well positioned with its “Better Growth” strategy and plans to continue driving growth with specialty fibers as well as its sustainability goals, including the transformation from a linear to a circular economy model.

The successful implementation of the key projects in Thailand and Brazil as well as the investment projects in China and Indonesia will further strengthen Lenzing’s positioning in this respect.

Taking into consideration the aforementioned factors and assuming a further market recovery in the current financial year, the Lenzing Group continues to expect EBITDA in a range between EUR 320 mn and EUR 420 mn for 2023.

 

*Source: ITMF, 21st Global Textile Industry Survey, July 2023

Source:

Lenzing AG

06.06.2023

Hohenstein celebrates 30 years of accreditation

On June 9, Hohenstein celebrates World Accreditation Day (WAD2023) along with 30 years as an accredited testing laboratory. In 1993, Hohenstein’s first lab received official certification to test textile products competently, reliably and impartially according to internationally recognized standards. With the expansion of its testing business, the company, headquartered in Boennigheim, Germany, has since gained numerous other accreditations for its global laboratories.

"The accreditations give our customers confidence that we comply with the required quality control procedures," says Julia Seeberg, who as Head of Quality Management also oversees the regular monitoring of the laboratories by DAkkS, the Deutsche Akkreditierungsstelle. “Everything possible is done to ensure the integrity of the test results.” In addition to DAkks accreditations of the testing laboratories for textile technological, biological, chemical and physical tests, Hohenstein is accredited as a certification and inspection body. Hohenstein's 75 years of expertise in the testing business complement its accreditation and provide an important basis for its long-standing customer trust.

On June 9, Hohenstein celebrates World Accreditation Day (WAD2023) along with 30 years as an accredited testing laboratory. In 1993, Hohenstein’s first lab received official certification to test textile products competently, reliably and impartially according to internationally recognized standards. With the expansion of its testing business, the company, headquartered in Boennigheim, Germany, has since gained numerous other accreditations for its global laboratories.

"The accreditations give our customers confidence that we comply with the required quality control procedures," says Julia Seeberg, who as Head of Quality Management also oversees the regular monitoring of the laboratories by DAkkS, the Deutsche Akkreditierungsstelle. “Everything possible is done to ensure the integrity of the test results.” In addition to DAkks accreditations of the testing laboratories for textile technological, biological, chemical and physical tests, Hohenstein is accredited as a certification and inspection body. Hohenstein's 75 years of expertise in the testing business complement its accreditation and provide an important basis for its long-standing customer trust.

Hohenstein laboratories in China, Bangladesh, Hong Kong and India have accreditations from the respective national and international accreditation bodies. The labs celebrate World Accreditation Day by highlighting the importance of accredited laboratories for the product quality and sustainability. "The demands of suppliers and consumers have increased," Julia Seeberg also notes. “For manufacturers to remain credible, it is even more imperative to demonstrate compliance with defined and standardized quality criteria.”

The globally valid quality standard for testing and calibration laboratories is DIN EN ISO/IEC 17025. The standard specifies general requirements for the competence, impartiality and uniform working methods of laboratories that operate internationally. Accreditations in accordance with DIN EN ISO/IEC 17020 and 17065 exist for the inspection and certification bodies. In addition, Hohenstein is an accredited testing laboratory for medical devices, where biological, chemical and physical laboratory tests are carried out. These tests form the basis for conformity with the European Medical Device Regulation (MDR).

Source:

Hohenstein

(c) SHIMA SEIKI MFG., LTD.
24.05.2023

SHIMA SEIKI at ITMA 2023

SHIMA SEIKI MFG., LTD. of Wakayama, Japan, will be participating in the International Textile Machinery Association exhibition (ITMA 2023) in Milan, Italy this June.

The Next-Generation group of machines is represented by the letter ‘R,’ first used in the SWG-XR WHOLEGARMENT® knitting machine launched last year in time for SHIMA SEIKI's 60th Anniversary event. The SWG-XR name is based on the original SWG-X four-needlebed WHOLEGARMENT® knitting machine which debuted at the Milan ITMA in 1995. As ITMA returns to Milan, SWG-XR refers to its origin as a pioneering invention that launched a new genre of seam-free knits produced in one entire piece. At the same time it represents a renewal of SHIMA SEIKI's commitment to its customers, the industry and the environment, as all aspects of the machine were re-evaluated in terms of its purpose, the way it is manufactured, how it is used and how it impacts the environment. The same renewal has been applied to the rest of the company's product lineup, and it is this renewal that becomes the core of SHIMA SEIKI's exhibition concept for ITMA 2023: "Reborn."

SHIMA SEIKI MFG., LTD. of Wakayama, Japan, will be participating in the International Textile Machinery Association exhibition (ITMA 2023) in Milan, Italy this June.

The Next-Generation group of machines is represented by the letter ‘R,’ first used in the SWG-XR WHOLEGARMENT® knitting machine launched last year in time for SHIMA SEIKI's 60th Anniversary event. The SWG-XR name is based on the original SWG-X four-needlebed WHOLEGARMENT® knitting machine which debuted at the Milan ITMA in 1995. As ITMA returns to Milan, SWG-XR refers to its origin as a pioneering invention that launched a new genre of seam-free knits produced in one entire piece. At the same time it represents a renewal of SHIMA SEIKI's commitment to its customers, the industry and the environment, as all aspects of the machine were re-evaluated in terms of its purpose, the way it is manufactured, how it is used and how it impacts the environment. The same renewal has been applied to the rest of the company's product lineup, and it is this renewal that becomes the core of SHIMA SEIKI's exhibition concept for ITMA 2023: "Reborn."

Of the 9 knitting machines SHIMA SEIKI is exhibiting, 8 machines will be part of the Next-Generation lineup, ranging from WHOLEGARMENT® knitting machines and computerized flat knitting machines to glove knitting machines. More than 300 items will be on display as proposals for knitted applications in various fields ranging from fashion, sports, shoes, bags and accessories to medical, safety, automotive, aeronautical and other wearable and industrial textile applications.

In addition to machine technology, SHIMA SEIKI's SDS-ONE APEX series computer graphic design system and software will be shown with their latest software upgrades that feature significant improvements in knit programming, 3D functions and speed. Demonstrations will be available for a comprehensive fashion tech solutions package based on realistic virtual sampling and supported by various digital solutions and web services.

More information:
Shima Seiki ITMA 2023 ITMA
Source:

SHIMA SEIKI MFG., LTD.

(c) FET
FET’s Director of Technology, Mark Smith and new R&D Manager, Dr Jonny Hunter
17.05.2023

FET strengthens its technical team

Fibre Extrusion Technology Ltd (FET) of Leeds, UK has strengthened its technical team with the appointment of Dr Jonny Hunter as Research & Development Manager. Hunter brings a wealth of academic credentials to the department, including a Master’s in Medicinal and Biological Chemistry and a PhD in Sustainable Chemistry. This academic background is complemented by over 10 years’ R&D experience in industry, including FMCG and, in particular, medical devices, which encompasses wound care, the medical device manufacturing process and regulatory environment.

Fibre Extrusion Technology Ltd (FET) of Leeds, UK has strengthened its technical team with the appointment of Dr Jonny Hunter as Research & Development Manager. Hunter brings a wealth of academic credentials to the department, including a Master’s in Medicinal and Biological Chemistry and a PhD in Sustainable Chemistry. This academic background is complemented by over 10 years’ R&D experience in industry, including FMCG and, in particular, medical devices, which encompasses wound care, the medical device manufacturing process and regulatory environment.

FET designs, develops and manufactures extrusion equipment for a wide range of high value textile material applications, so the above research and industrial sectors have great relevance to the company’s focus on the international stage. A significant market for FET’s meltspinning equipment is medical devices, so in-house expertise in this area is a vital commodity. FET is also at the forefront of innovation to promote and develop sustainable fibres, so technical knowhow in sustainability is also essential. In this, Jonny Hunter has considerable experience and has in the past lead a number of innovation projects in sustainable chemistry and management.

This fresh input of knowledge and experience will benefit FET’s customers in their own drive for sustainable innovation in fibre technology. Mark Smith, the previous R&D Manager, is taking a short sabbatical and will be returning in a more strategic role as FET’s Director of Technology, so his continued presence will further contribute to FET’s breadth of technical expertise.

FET has also expanded in a number of other departments to reflect the rapid growth in sales over recent years. Mike Urey is the new Sales Engineer, bringing a wide industrial experience and strengthening all aspects of business development. Three new mechanical and electronic engineers and a new appointment in the design department all combine to take the company forward and sustain growth.

Source:

Fibre Extrusion Technology Ltd (FET)

(c) FET
FET Melt Spinning system
05.05.2023

FET exhibits at ITMA 2023

Fibre Extrusion Technology Ltd (FET) of Leeds, UK will be exhibiting at ITMA 2023, taking place between 8-14 June Milan, Italy. FET has commissioned its biggest ever stand to reflect the company’s commitment to this event and the textile industry.

FET designs, develops and manufactures extrusion equipment for a wide range of high value textile material applications worldwide. Central to FET’s success has always been its ability to provide customers with advanced facilities and equipment, together with unrivalled knowledge and expertise in research and production techniques.

The new FET Fibre Development Centre will further improve this service, allowing clients to trial their own products in an ideal environment. Resident equipment in the Fibre Development Centre reflects the wide range of fibre extrusion systems offered by FET to clients worldwide and will enable continued growth of the company through innovation.  

Fibre Extrusion Technology Ltd (FET) of Leeds, UK will be exhibiting at ITMA 2023, taking place between 8-14 June Milan, Italy. FET has commissioned its biggest ever stand to reflect the company’s commitment to this event and the textile industry.

FET designs, develops and manufactures extrusion equipment for a wide range of high value textile material applications worldwide. Central to FET’s success has always been its ability to provide customers with advanced facilities and equipment, together with unrivalled knowledge and expertise in research and production techniques.

The new FET Fibre Development Centre will further improve this service, allowing clients to trial their own products in an ideal environment. Resident equipment in the Fibre Development Centre reflects the wide range of fibre extrusion systems offered by FET to clients worldwide and will enable continued growth of the company through innovation.  

For the first time at ITMA, the new FET Spunbond range will feature. This system provides opportunities for the scaled development of new nonwoven fabrics based on a wide range of fibres and polymers, including bicomponents. Recent customers to benefit from FET spunbond systems include the University of Leeds and an integrated metlblown / spunbond system at the University of Erlangen-Nuremberg in Germany.

FET’s established expertise remains in laboratory and pilot meltspinning equipment for a vast range of applications, such as precursor materials used in high value technical textiles, sportswear, medical devices and specialised novel fibres from exotic and difficult to process polymers. FET has successfully processed almost 30 different polymer types in multifilament, monofilament and non-woven formats, collaborating with specialist companies worldwide to promote greater sustainability through innovative manufacturing processes. Where melt spinning solutions are not suitable, FET provides a viable alternative with pilot and small scale production wet spinning systems.

A major theme at ITMA will again be sustainability. The FET range of laboratory and pilot extrusion lines is ideally suited for both process and end product development of sustainable materials. “This year we are celebrating FET’s 25th anniversary” says FET Managing Director Richard Slack “and we look forward to meeting customers at ITMA, where we can discuss their fibre technology needs.”

Source:

Fibre Extrusion Technology Ltd

03.05.2023

Lenzing: Outlook for 2023

  • Revenue grows to EUR 623.1 mn – fiber sales recovered over the course of the quarter
  • EBITDA and net result for the period down compared with the first quarter of 2022
  • Cost reduction program of more than EUR 70 mn being implemented according to plan
  • Production of TENCEL™ brand modal fibers successfully launched in China
  • Lenzing confirms guidance for 2023

The business performance of the Lenzing Group during the first quarter of 2023 largely reflected market trends. However, after the market environment had deteriorated significantly in the third and fourth quarters of the previous year, signs of recovery emerged during the first quarter in terms of demand as well as raw material and energy costs. Textile fibers recorded moderate but steadily improving demand. Business with fibers for nonwovens and with dissolving wood pulp performed better than expected. Raw material and energy costs were still at an elevated albeit decreasing level.

  • Revenue grows to EUR 623.1 mn – fiber sales recovered over the course of the quarter
  • EBITDA and net result for the period down compared with the first quarter of 2022
  • Cost reduction program of more than EUR 70 mn being implemented according to plan
  • Production of TENCEL™ brand modal fibers successfully launched in China
  • Lenzing confirms guidance for 2023

The business performance of the Lenzing Group during the first quarter of 2023 largely reflected market trends. However, after the market environment had deteriorated significantly in the third and fourth quarters of the previous year, signs of recovery emerged during the first quarter in terms of demand as well as raw material and energy costs. Textile fibers recorded moderate but steadily improving demand. Business with fibers for nonwovens and with dissolving wood pulp performed better than expected. Raw material and energy costs were still at an elevated albeit decreasing level.

Outlook
The war in Ukraine and the more restrictive monetary policy pursued by many central banks in order to combat inflation are expected to continue to influence global economic activity. The IMF warns that risks remain elevated overall and forecasts growth of 2.8 and 3 percent for 2023 and 2024 respectively. The currency environment is expected to remain volatile in the regions relevant to Lenzing.

This market environment continues to weigh on the consumer climate and on sentiment in the industries relevant to Lenzing. However, the outlook has brightened somewhat recently.

Demand picked up tangibly after the Chinese New Year. As a consequence, capacity utilization improved and stocks were further reduced both at viscose producers and at downstream stages of the value chain.

In the trend-setting market for cotton, signs are emerging of a further buildup of stocks in the current 2022/23 crop season. Initial forecasts for 2023/24 anticipate a more balanced relationship between supply and demand.

However, despite signs of recovery in both demand and raw material and energy costs, earnings visibility remains limited overall.

Lenzing is fully on track with the implementation of the reorganization and cost reduction program. These and other measures are aimed at positioning Lenzing in the best possible way for the expected market recovery.

Structurally, Lenzing continues to anticipate growth in demand for environmentally responsible fibers for the textile and clothing industry as well as for the hygiene and medical sectors. As a consequence, Lenzing is very well positioned with its “Better Growth” strategy and plans to continue driving growth with specialty fibers as well as its sustainability goals, including the transformation from a linear to a circular economy model.

The successful implementation of the key projects in Thailand and Brazil as well as the investment projects in China and Indonesia will further strengthen Lenzing’s positioning in this respect.

Taking into account the aforementioned factors and assuming a further market recovery in the current financial year, the Lenzing Group continues to expect EBITDA in a range between EUR 320 mn and EUR 420 mn for 2023.

Source:

Lenzing AG

(c) INDEX™ | Palexpo SA
26.04.2023

INDEX™23 concludes successfully with over 610 exhibitors

The international nonwovens community came together once again in Geneva this week for INDEX™23, with with 12,017 attendees from over 100 countries and 610 exhibitors from 43 countries joining the event.

Exhibitors made the most of the four intensive days to meet potential new customers and extend business with existing clients. As one of the world’s leading nonwovens exhibitions, INDEX™ demonstrated the latest breakthroughs and innovative developments across all nonwovens’ applications.

The INDEX™ Lab, an exchange hub displaying samples from innovations and new developments, also showcased the winners and runners up from each of the five categories of the INDEX™ Innovation Award. Open to any EDANA member company or exhibitor at INDEX™23, the winners were announced on the first day of the exhibition during a dedicated ceremony at the EDANA stand.

The winners (more infomation):

The international nonwovens community came together once again in Geneva this week for INDEX™23, with with 12,017 attendees from over 100 countries and 610 exhibitors from 43 countries joining the event.

Exhibitors made the most of the four intensive days to meet potential new customers and extend business with existing clients. As one of the world’s leading nonwovens exhibitions, INDEX™ demonstrated the latest breakthroughs and innovative developments across all nonwovens’ applications.

The INDEX™ Lab, an exchange hub displaying samples from innovations and new developments, also showcased the winners and runners up from each of the five categories of the INDEX™ Innovation Award. Open to any EDANA member company or exhibitor at INDEX™23, the winners were announced on the first day of the exhibition during a dedicated ceremony at the EDANA stand.

The winners (more infomation):

  1. Nonwoven roll goods
    Winner: Suominen – HYDRASPUN® Circula Nonwoven
  2. Finished products made from, or incorporating nonwovens
    Winner: Henkel – Smart Adult Care
  3. Raw materials or components (e.g., fibre, binder, polymer, tape), of special relevance to the nonwovens industry and related converted products
    Winner: Fiberpartner – BicoBio
  4. Innovation in machinery of special relevance to the nonwovens industry
    Winner: Curt G. Joa, Inc. – ESC-8™
  5. Sustainable Product
    Winner: Sparkle Innovations – SugaFluff™

The "Nonwovens Journey", an immersive experience that takes a look at the innovative role of nonwovens, as well as how innovation has progressed in time around both sustainability, and how nonwovens are used in everyday life, also allowed visitors to discover the versatility of nonwovens.

Running alongside the exhibition itself, there was also a full programme of side events that were enjoyed by participants: Exhibitor Product Presentations from 33 exhibitors; a series of informative seminars covering a myriad of topics including medical nonwovens, sustainability, circular economy, geosynthetics, textiles, mobility, fair trade, gender equity, innovation, and market trends; country-specific briefings offering insights into the nonwovens market in various regions around the world; and a nonwovens tutorial intended as an induction to nonwovens for those new to the industry. These topics were all presented by leading industry experts and guest speakers, including among others, the World Trade Organization (WTO).

Concern for the environment has in recent years become increasingly important, and once again remained a key topic at INDEX™23, with companies pushing to achieve further CO2 reductions and circularity across the supply chain.

Continuing on from its success during COVID-19, the INDEX™23 Mobile App and Virtual Platform was back. This tool offered participants – both in Geneva and those following from home – the chance to watch presentations live and interact with speakers, exhibitors, and other participants. Attendees were able to plan their visit and organize meetings, which was highly appreciated. Video recordings from the sessions will remain available online in the app and platform for the coming weeks.

The next INDEX™ will take place in three years from 21-24 April 2026.

Source:

INDEX™ | Palexpo SA

Celliant -how it works (c) Hologenix
06.04.2023

Hologenix: Infrared technology with potentially positive impact on diabetic patients

The diabetic community has always been a priority for Hologenix, creators of CELLIANT® infrared technology, so the company embarked on an initial study to test the hypothesis that the technology can positively impact diabetic patients with vascular impairment, now published in Journal of Textile Science & Engineering. Another study is underway as well with more research on the horizon.

The diabetic community has always been a priority for Hologenix, creators of CELLIANT® infrared technology, so the company embarked on an initial study to test the hypothesis that the technology can positively impact diabetic patients with vascular impairment, now published in Journal of Textile Science & Engineering. Another study is underway as well with more research on the horizon.

According to statistics cited in the International Diabetes Federation Diabetes Atlas, 9th edition, globally, close to a half billion people are living with diabetes and that number is expected to increase by more than 50 percent in the next 25 years.
 
The introduction of the study in the Journal of Textile Science & Engineering also reports that diabetic patients frequently suffer from a combination of peripheral neuropathy and peripheral artery disease, which particularly affects their feet. It further states that it has been estimated that the lifetime risk for the development of foot ulcers in diabetic patients can be as high as 25 percent and that the risk of amputation is 10 to 20 times higher than in non-diabetic subjects.
 
The study was performed by Lawrence A. Lavery, D.P.M., M.P.H., a Professor in the Department of Plastic Surgery at UT Southwestern Medical Center. His clinic and research interests involve diabetic foot complications, infections and wound healing, and he participated in the conception, design, implementation and authorship of the Journal of Textile Science & Engineering study.  

CELLIANT technology is a patented process for adding micron-sized thermo-responsive mineral particles to fibers, in this case polyethylene terephthalate (PET) fibers. The resulting CELLIANT yarns were woven into stockings and gloves containing either 82% CELLIANT polyester, 13% nylon and 5% spandex or for the placebo, 82% polyester with no CELLIANT, 13% nylon and 5% spandex. CELLIANT products absorb body heat and re-emit the energy back to the body as infrared energy, which is non-invasive and increases temporary blood flow and cell oxygenation levels in the body.

The objective of the study was to “evaluate changes in transcutaneous oxygen (TcPO2) and peripheral blood flow (laser Doppler, LD) in the hands and feet of diabetic patients with vascular impairment when CELLIANT gloves and stockings are worn.” While there was not a statistically significant result across all subjects, the study did show that some patients wearing CELLIANT stockings for 60 minutes had an increase of as much as 20% in tissue oxygenation and 30% in localized blood flow. According to the study’s conclusion, “the trends that were observed in favor of CELLIANT stockings suggest that a larger well-designed clinical trial should be undertaken and may provide evidence of clinical efficacy in treatment of the diabetic foot.”
 
The study also notes that “There have been no documented or observed side effects of wearing CELLIANT stockings, and they are relatively inexpensive compared to conventional pharmaceutical interventions.”

Hologenix has embarked on a more comprehensive trial, “Study to Evaluate CELLIANT Diabetic Medical Socks to Increase Tissue Oxygenation and Incidence of Complete Wound Closure in Diabetic Foot Wounds” – NCT04709419, which focuses on the impact of CELLIANT technology to potentially improve tissue oxygenation and wound healing outcomes.
 
“We are excited to explore whether future studies of infrared, with its most common biological effects of increased localized blood flow and cellular oxygenation, could result in a breakthrough in diabetic patients with vascular impairment,” said Seth Casden, Hologenix Co-founder and CEO. “We see a huge potential opportunity with this research for helping to fulfill our core mission of improving people’s health and well-being by potentially reducing the impact of diabetes, and we are actively seeking partners to expand our research efforts.”

Source:

Hologenix

(c) SABIC
05.04.2023

SABIC presents portfolio for healthcare and hygiene market at INDEX™23

SABIC will present its portfolio of PURECARES™ and TRUCIRCLE™ materials for the healthcare and hygiene market at INDEX™23 from April 18 to 21 in Geneva, Switzerland, under the theme of ‘Collaborating for sustainability and innovative solutions’.

At INDEX, SABIC will highlight a joint project with two market leaders, using certified circular polymers from the TRUCIRCLE portfolio in recyclable films for feminine hygiene, baby care and disposable medical applications. In all of these cases from diapers to surgical drapes and medical gowns, the sustainable materials can serve as direct drop-in alternatives with no compromise in production efficiency and product performance.

Further examples on display at the company’s booth will feature TRUCIRCLE solutions for facemasks, including an N95 design that localizes the value chain with SABIC® PURECARES PP spunbond and meltblown polymers in Saudi Arabia. SABIC provides complete solutions for facemask production as part of its localization strategy and has been a key enabler of the Saudi Made initiative. Also shown will be a closed-loop facemask developed in collaboration with industrial and research partners in Europe.

SABIC will present its portfolio of PURECARES™ and TRUCIRCLE™ materials for the healthcare and hygiene market at INDEX™23 from April 18 to 21 in Geneva, Switzerland, under the theme of ‘Collaborating for sustainability and innovative solutions’.

At INDEX, SABIC will highlight a joint project with two market leaders, using certified circular polymers from the TRUCIRCLE portfolio in recyclable films for feminine hygiene, baby care and disposable medical applications. In all of these cases from diapers to surgical drapes and medical gowns, the sustainable materials can serve as direct drop-in alternatives with no compromise in production efficiency and product performance.

Further examples on display at the company’s booth will feature TRUCIRCLE solutions for facemasks, including an N95 design that localizes the value chain with SABIC® PURECARES PP spunbond and meltblown polymers in Saudi Arabia. SABIC provides complete solutions for facemask production as part of its localization strategy and has been a key enabler of the Saudi Made initiative. Also shown will be a closed-loop facemask developed in collaboration with industrial and research partners in Europe.

The company’s PURECARES polyolefin products are based on technologies free of both tris (nonylphenyl) phosphite (TNPP) and phthalates. Consumer comfort is achieved by using SABIC polypropylene (PP) and polyethylene (PE) polymers for bi-component fibers to answer multiple needs for soft and loft handfeel nonwovens, enabling easy lamination to other building blocks on medical nonwovens or absorbent hygiene applications.

In addition, SABIC produces TRUCIRCLE certified circular polymers for its PURECARES PP and PE portfolio with feedstock based on advanced recycling of mixed and used plastic that would otherwise typically not be suitable for mechanical recycling processes. These more sustainable solutions can be adopted in downstream processes as direct drop-in alternatives to incumbent materials with no compromise in production efficiency, purity and product performance.

Source:

SABIC

10.03.2023

Lenzing Group: Difficult market environment and strategic success in 2022

  • Revenue rose to EUR 2.57 bn, while EBITDA declined to EUR 241.9 mn
  • Implementation of EUR 70 mn cost reduction program proceeding according to plan
  • Largest investment program in the company’s history including the lyocell plant in Thailand and the pulp mill in Brazil implemented on time and within budget
  • Outlook: Lenzing expects EBITDA in 2023 to be in a range of EUR 320 mn to EUR 420 mn

The Lenzing Group was increasingly affected by extreme developments on the global energy and raw material markets in the 2022 financial year, in tandem with most of manufacturing industry in Europe. The market environment also deteriorated significantly in the third and fourth quarters, while worsening consumer sentiment placed an additional burden on Lenzing’s business growth.

  • Revenue rose to EUR 2.57 bn, while EBITDA declined to EUR 241.9 mn
  • Implementation of EUR 70 mn cost reduction program proceeding according to plan
  • Largest investment program in the company’s history including the lyocell plant in Thailand and the pulp mill in Brazil implemented on time and within budget
  • Outlook: Lenzing expects EBITDA in 2023 to be in a range of EUR 320 mn to EUR 420 mn

The Lenzing Group was increasingly affected by extreme developments on the global energy and raw material markets in the 2022 financial year, in tandem with most of manufacturing industry in Europe. The market environment also deteriorated significantly in the third and fourth quarters, while worsening consumer sentiment placed an additional burden on Lenzing’s business growth.

In the year under review, revenue increased by 16.9 percent year-on-year to reach EUR 2.57 bn, primarily as a result of higher fiber prices. The quantity of fiber sold decreased, while the quantity of pulp sold rose. In addition to lower demand, the earnings trend particularly reflects the increase in energy and raw material costs. Earnings before interest, tax, depreciation and amortization (EBITDA) decreased by 33.3 percent year-on-year to EUR 241.9 mn in 2022. The net result for the year was minus EUR 37.2 mn (compared with EUR 127.7 mn in the 2021 financial year), while earnings per share stood at minus EUR 2.75 (compared with EUR 4.16 in the 2021 financial year).

Outlook
The war in Ukraine and the tighter monetary policy pursued by many central banks to combat inflation will continue to exert pressure on the global economy. The easing of China’s zero-Covid policy could lead to an unexpectedly rapid recovery. However, the IMF has warned that risks remain high overall and projects growth of 2.9 percent in 2023. Exchange rate volatility looks set to continue in regions that are important to Lenzing.

These challenging market conditions are also continuing to weigh on consumer confidence and sentiment in the sectors relevant to Lenzing. The outlook has improved slightly of late, with inventory levels returning to normal across the value chain. Nonetheless, subdued demand remains a source of concern for market players.

Inventories in the bellwether cotton market have diminished recently, although they remain above pre-pandemic levels. A decline in crops is foreseeable in the current 2022/2023 harvest season. The sharp rise in prices on the energy and raw material markets will continue to pose significant challenges for the market.

Overall, earnings visibility remains restricted.

In structural terms, Lenzing expects a continued rise in demand for environmentally friendly fibers in the textile and clothing industry, as well as in the hygiene and medical sectors. Thus, with its “Better Growth” strategy, Lenzing is very well positioned and will continue to drive growth in specialty products, while pursuing its sustainability targets including the transformation from a linear to a circular economy model.

In light of these factors and assuming a further market recovery in the current financial year, the Lenzing Group expects EBITDA in 2023 to be in a range of EUR 320 mn to EUR 420 mn.

Source:

Lenzing AG

13.02.2023

CELLIANT cleared to market in 50+ countries

  • Registered in majority as a class 1 medical device  

CELLIANT -  a performance textile that converts body heat into infrared energy - is designated as a Class 1 Medical Device in Australia, Canada, the EU and European Economic Area (EEA), Japan, New Zealand, the United Arab Emirates, the United Kingdom and the United States. CELLIANT is cleared to market in China, India, Indonesia, Korea, Malaysia, Mexico, Peru, Philippines, Russia, Saudi Arabia, Singapore, South Africa, Taiwan, Thailand and Vietnam, with more countries and regions to follow.

  • Registered in majority as a class 1 medical device  

CELLIANT -  a performance textile that converts body heat into infrared energy - is designated as a Class 1 Medical Device in Australia, Canada, the EU and European Economic Area (EEA), Japan, New Zealand, the United Arab Emirates, the United Kingdom and the United States. CELLIANT is cleared to market in China, India, Indonesia, Korea, Malaysia, Mexico, Peru, Philippines, Russia, Saudi Arabia, Singapore, South Africa, Taiwan, Thailand and Vietnam, with more countries and regions to follow.

In 2017, the FDA determined that products containing CELLIANT are medical devices as defined in section 201(h) of the Federal Food, Drug and Cosmetic Act and are general wellness products because they are intended to temporarily increase blood flow and local circulation at the site of the application in healthy individuals.
 
At Hologenix®, whose CELLIANT® infrared technology is an ingredient in world-class brands across many categories, science matters. The company has a distinguished Science Advisory Board composed of experts in the fields of photobiology, nanotechnology, sleep medicine, diabetes and wound care. The Science Advisory Board has overseen nine peer-reviewed published studies that collectively demonstrate CELLIANT’s effectiveness and the benefits of infrared energy. This claim set provides the basis for products containing CELLIANT to be designated as a Class 1 Medical Device in 38 countries and cleared to market in 15, with more countries and regions to follow. This elevated status in 53 countries translates to CELLIANT being an ideal partner for global companies who are seeking innovation in textiles to distinguish their products.   

“We have laid the groundwork for our partner brands to capitalize on the benefits of our infrared technology and to enhance their ability to do business,” said Seth Casden, Hologenix co-founder and CEO.  “We firmly believe that regulatory status matters and that is why we have grown the number of countries we have such relationships with by over a third in the last three years. It is definitely a competitive advantage of our company and CELLIANT.”

“Globally, the awareness of the benefits of infrared textiles, which absorb body heat and reflect it back as therapeutic infrared energy, has grown exponentially over the last 10 years,” continued Casden. “And in the United States infrared is gaining a strong foothold.”

Source:

Hologenix